Dislocation

Dislocation — what exactly happened to the price

There is a real dislocation, with a dated trigger. NICE fell 40.6% from its 5-March-2026 peak (₪414.2) to a 19-June trough (₪246.2), and sits at ₪291.8 — 29.6% below the high. The event leg was the 6-May Q1 2026 report: a revenue and EPS beat with raised full-year EPS guidance, sold off 18.8% in one session on a soft Q2 growth guide and AI-driven retention pressure. The price fall far outran the estimate change.

NICE reports its financial results in US dollars but its shares trade in shekels (₪) on the Tel Aviv Stock Exchange (with NASDAQ ADRs). Price and drawdown figures below are in ₪; revenue, EPS, and guidance are in $ as the company reports them. A companion page restates the price levels in dollars.

The drawdown — a 41% fall in one quarter, with a clean event leg

Source: daily price history, TASE close (data/prices/daily.json); drawdown levels and −40.56% depth per the deterministic feature file (fit_features.capitulation_gauge.drawdown).

The peak-to-trough fall of 40.6% took 106 days and ran in two distinguishable phases. From the 5-March high of ₪414.2, the stock drifted down to about ₪302 by late April — a 27% decline with no NICE-specific event and only moderate volume, the kind of drift the framework treats as the start of the slide rather than the moment. It then spiked 21.3% to ₪372.5 on 4 May on reports that NICE had drawn roughly $2.5 billion of bids for its Actimize financial-crime unit [1]. Two sessions later the event leg hit: a single-day 18.8% collapse on 6 May that reset the trend and carried price to the ₪246.2 trough on 19 June before a partial recovery to ₪291.8.

A caution on the raw series: the price feed is a six-month web-sourced history (23 January to 21 July 2026), so the ₪414.2 "peak" is the high of this window, not a verified multi-year top, and the 180-day pre-peak baseline used for the volume gauge is truncated to about 30 trading days. The percentage drawdown is robust to these limits; the absolute shekel levels should be read as the feed reports them.

The trigger — a beat-and-raise the market sold 18.8%

The dated adverse event is the first-quarter 2026 report, released 6 May 2026 before the US open [2]. On its face the print was strong. Revenue of $768.6 million rose 9.8% and beat consensus by 1.0%; non-GAAP EPS of $2.64 beat by 4.8%; both cleared the high end of guidance, and management raised full-year EPS guidance to $10.98–$11.18 [3]. AI ARR grew 66% year over year to $345 million. Against that, the stock fell from a ₪369.9 intraday high to a ₪287.2 low, closing down 18.8%.

Source: reported actuals, Q1 2026 press release [4]; consensus as-of from CapIQ estimates (data/sp/estimates.json, beat_miss).

What repriced the stock was the forward setup, not the quarter. Three items in the same release and call carried the signal:

• Second-quarter revenue guidance of $761–771 million implies just 5.5% year-over-year growth at the midpoint — a sharp step down from the 9.8% just reported [5]. Full-year cloud growth was guided to 13%–15% [6], well below the roughly 25% cloud growth NICE ran two years earlier.
• Cloud net revenue retention fell to 107%. The CFO tied it directly to the AI transition: "we are seeing some near term pressure on NRR as we continue to transition our portfolio towards AI driven capabilities which can result in compression in certain CX components" [7].
• Pricing concessions to marquee accounts created a Q2 timing hole: management took "renewal specific commercial actions to accelerate AI expansion," producing "phasing effects… with a more pronounced impact expected in Q2," so Q2 cloud growth would run "slightly below our full year range" [8].

The mechanism behind the fear is concrete: agentic AI displaces the human contact-center seats NICE has historically billed against, and the AI ARR growing at 66% is not yet large enough (14% of cloud) to offset the seat compression showing up in retention. Organic cloud growth, stripping out the Cognigy acquisition, was closer to 12% than the headline 14.6% [9]. The market repriced NICE's growth trajectory and multiple, not its 2026 earnings line — which management raised.

This is not the first time. The identical pattern — a beat overwhelmed by a soft cloud guide and AI-substitution worry — drove a roughly 20% single-quarter plunge in November 2025 and a plunge on the February 2025 outlook [10]. The 6-May move is the latest and largest instance in the corpus, and it is the leg that defines this drawdown.

The fear gauge — capitulation volume, clustered late in the fall

Source: daily volume (data/prices/daily.json); spike multiples per the feature file (fit_features.capitulation_gauge.volume_spike) and data/tech/unusual_volume.json.

The volume did spike, and the measured multiple is 3.3x — the peak-to-trough leg's heaviest 20-day average volume against the median daily volume of the 180 days before the peak (fit_features.capitulation_gauge.volume_spike). Two features matter for reading it as emotion-driven rather than orderly. First, the event day itself (6 May) traded 665,650 shares, 2.83x its 50-day average, confirming forced repricing on the news [11]. Second, and more telling, the single heaviest session of the entire window was 29 May at 4.73 million shares — 13.8x the 50-day average — on a close of ₪250.1 that moved only −3.0%. High volume with almost no price change, arriving near the trough rather than at the March top, is the washout signature: the marginal seller was being cleared out late in the fall, consistent with the framework's "peak fear, not the start of the slide." (The May-29 anomaly is also consistent with index-rebalancing flow, though the corpus does not confirm a specific index event.)

Who was selling — a data gap on shorts, and a company buying its own fall

Official short-interest data is not available for a TASE-listed security in this run: no deterministic public short-interest source is configured for Israel, and the latest snapshot returns status "unavailable" (data/short_interest/latest.json). Short-interest level and change cannot be quantified here — a genuine gap, not a zero.

What the record does show is that the largest identifiable buyer through the drawdown was the company itself. NICE repurchased a record $253 million of stock in Q1 2026 — about 3.5% of its market capitalization — cutting weighted diluted shares roughly 5% year over year to about 58.5 million, and exited the quarter with $745 million of buyback authorization remaining and a commitment to repurchase more than 50% of free cash flow for the year [12]. On the seller side, the recurring "sell-the-guide" reaction across three consecutive outlook events (Feb 2025, Nov 2025, May 2026) points to a holder base that repeatedly repositions on decelerating cloud guidance rather than to a single forced liquidation [13]. No fund liquidation, index exit, or insider sale is disclosed in the corpus. The seller composition is therefore best described as anchored, guidance-reactive selling against a heavy corporate bid — with the short leg unquantifiable.

Estimates versus price — the fall outran the cut

This is the framework's signature, and it is pronounced here. Across the drawdown, forward estimates barely moved while price fell 40.6%. Full-year 2027 revenue consensus was trimmed only 1.3%, from $3,532 million in January to $3,486 million by June; over the same span, 2027 EPS consensus was revised up 5.1%, from $12.49 in April to $13.13 by July (CapIQ consensus). At the event itself the company raised full-year 2026 EPS guidance to $10.98–$11.18 rather than cutting it [14], and consensus 2026 EPS sits near $11.11, inside that raised range.

Source: price per fit_features.capitulation_gauge; estimate revisions from CapIQ momentum series (data/sp/estimates.json), FY2027 revenue and normalized EPS.

Consensus estimates fell fractionally, and after — not before — the price; the near-term FCF path dips modestly (FY2026 consensus FCF $589.8 million against FY2025's $648.6 million) before reaccelerating to $694.8 million in FY2027, per CapIQ consensus. A price that fell 40.6% while forward EPS estimates were flat-to-higher is a fall driven by multiple compression, not by the earnings the sell side actually forecasts. Whether that compression is deserved — whether AI-driven seat displacement permanently impairs NICE's economics or merely reprices one year — belongs to the Damage Math tab and the trial, not here.

Bottom line

NICE presents a genuine dislocation with a dated trigger and capitulation volume: a 40.6% peak-to-trough fall whose defining leg was the 18.8% single-session drop on the 6-May-2026 Q1 report — a revenue-and-EPS beat with raised full-year EPS guidance, sold off on a 5.5% Q2 revenue guide, cloud growth decelerating to 13%–15%, and net-revenue-retention compression the CFO attributed to the AI transition. Volume spiked 3.3x with the heaviest, lowest-price-change session near the trough. Forward estimates fell only low-single-digits — EPS actually rose — so the price fall clearly outran the estimate change. The unquantifiable short-interest picture and the six-month, shekel-denominated price feed are the honest caveats.